Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H19N3S |
Molecular Weight | 261.386 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
InChI
InChIKey=HNJJXZKZRAWDPF-UHFFFAOYSA-N
InChI=1S/C14H19N3S/c1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14/h3-8,11H,9-10,12H2,1-2H3
Molecular Formula | C14H19N3S |
Molecular Weight | 261.386 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB04819
Sources: http://www.drugbank.ca/drugs/DB04819
Methapyrilene is an antihistamine and anticholinergic of the pyridine chemical class which was developed in the early 1950s. It was sold under the trade names Co-Pyronil and Histadyl EC. It has relatively strong sedative effects, to the extent that its primary use was as a medication for insomnia rather than for its antihistamine action. Together with scopolamine, it was the main ingredient in Sominex, Nytol, and Sleep-Eze. It also provided the sedative component of Excedrin PM. Manufacturers voluntarily withdrew methapyrilineb drug products from the market in May and June 1979, when methapyrilene was demonstrated to cause liver cancer in rats when given chronically.
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
2.5 g single, oral Overdose |
healthy, 19 years |
Other AEs: Dizziness, Stomach cramps... |
25 mg single, intravenous Dose: 25 mg Route: intravenous Route: single Dose: 25 mg Sources: |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
|
50 mg single, oral |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Delusions | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Dizziness | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Stomach cramps | 2.5 g single, oral Overdose |
healthy, 19 years |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene. | 1998 Nov |
|
The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results. | 2001 |
|
Principal component analysis of mass spectra of peptides generated from the tryptic digestion of protein mixtures. | 2001 |
|
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. | 2001 Aug 15 |
|
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. | 2001 Mar 31 |
|
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. | 2001 Sep |
|
Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen. | 2001 Summer |
|
Fluorescence polarization discriminates green fluorescent protein from interfering autofluorescence in a microplate assay for genotoxicity. | 2002 Apr 18 |
|
Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. | 2002 Jul |
|
Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. | 2002 Jul-Aug |
|
Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. | 2002 Nov |
|
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. | 2005 Sep 29 |
|
Gene expression analysis of the hepatotoxicant methapyrilene in primary rat hepatocytes: an interlaboratory study. | 2006 Jan |
|
Recent applications of DNA microarray technology to toxicology and ecotoxicology. | 2006 Jan |
|
Tissue distribution of quetiapine in 20 cases in Virginia. | 2006 May |
|
Aqua-(2,2'-bipyridine-κN,N')bis-(thio-phene-2-carboxyl-ato-κO)copper(II). | 2009 Jul 11 |
|
Toxicogenomic biomarkers for liver toxicity. | 2009 Mar |
|
Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. | 2010 Aug 16 |
|
Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. | 2010 Dec |
|
Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. | 2011 Dec |
|
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. | 2012 |
|
Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. | 2012 Aug |
|
Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver. | 2012 Sep |
|
Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes. | 2013 Feb |
|
Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats. | 2014 |
|
Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAs. | 2014 Aug 1 |
|
Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats. | 2014 Oct 3 |
|
Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury. | 2014 Oct 3 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2046705
Methapyrilene failed to induce formation of DNA adducts in L5178Y cell DNA at doses which induced mutations at the thymidine kinase locus. These data suggest that methapyrilene induces mutations in this system through an indirect genotoxic mechanism; e.g., via an oxidative mechanism or interaction with chromosomal proteins.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:14:41 GMT 2023
by
admin
on
Fri Dec 15 16:14:41 GMT 2023
|
Record UNII |
A01LX40298
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
||
|
WHO-ATC |
R06AC05
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
||
|
WHO-VATC |
QR06AC05
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1411979
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
DTXSID2023278
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
6822
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
6820
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
DB04819
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
91-80-5
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
4163
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
1738
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
1883
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
m7301
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
4098
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
C81143
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
Methapyrilene
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
SUB08839MIG
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
100000081208
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
A01LX40298
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
202-099-8
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY | |||
|
D008701
Created by
admin on Fri Dec 15 16:14:41 GMT 2023 , Edited by admin on Fri Dec 15 16:14:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |